marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2023-Q2
added 08-03-2023
Axcella Health Financial Ratios 2011-2024 | AXLA
Annual Financial Ratios Axcella Health
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.3 | -1.0 | -3.6 | -1.4 | - | - | - | - | - | - | - | - |
P/S |
- | - | - | - | - | - | - | - | - | - | - | - |
EPS |
-1.5 | -1.7 | -1.8 | -3.5 | -8.0 | - | - | - | - | - | - | - |
EV (Enterprise Value) |
22.6 M | 77.3 M | 164 M | 22.7 M | -46.1 M | 165 M | - | - | - | - | - | - |
EBITDA per Share |
-1.41 | -1.62 | -1.44 | -3.42 | - | - | - | - | - | - | - | - |
EV/EBITDA |
-0.8 | -2.9 | -0.2 | - | - | - | - | - | - | - | - | |
PEG |
- | -0.07 | 0.02 | - | - | - | - | - | - | - | - | |
P/B |
6.0 | 3.0 | 2.7 | 1.3 | - | - | - | - | - | - | - | - |
P/CF |
-0.4 | -1.2 | -4.0 | -1.6 | - | - | - | - | - | - | - | - |
ROE % |
-1949.71 | -293.66 | -74.99 | -98.03 | - | - | - | - | - | - | - | - |
ROA % |
-428.94 | -111.95 | -51.58 | -62.57 | - | - | - | - | - | - | - | - |
ROCE % |
-1848.90 | -281.02 | -52.88 | -66.79 | - | - | - | - | - | - | - | - |
Current Ratio |
1.3 | 1.6 | 14.0 | 11.2 | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Axcella Health
| 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.05 | -0.05 | - | -0.34 | -0.4 | -0.46 | - | -0.41 | -0.42 | -0.4 | - | -0.34 | -0.48 | -0.65 | - | -0.75 | -0.95 | -2.43 | - | -1.85 | -2.15 | -1.92 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | -0.06 | - | -0.32 | -0.39 | -0.44 | - | -0.38 | -0.4 | -0.38 | - | -0.31 | -0.44 | -0.62 | - | -0.71 | -0.9 | -2.27 | - | -1.55 | -1.88 | -1.71 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
76.73 | -303.57 | -56.60 | -100.50 | -380.65 | -184.64 | -101.68 | -118.18 | -90.77 | -76.06 | -54.84 | -83.57 | -95.81 | -101.37 | -71.94 | -66.07 | -31.47 | -1.19 | 17.57 | 17.57 | 11.70 | 5.41 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-183.81 | -189.67 | -128.42 | -151.11 | -115.85 | -92.77 | -58.32 | -69.67 | -58.33 | -51.45 | -37.72 | -56.06 | -63.05 | -65.68 | -45.91 | -56.65 | -49.04 | -45.24 | -32.14 | -32.14 | -21.41 | -9.90 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
34.21 | -344.46 | -56.74 | -98.65 | -366.89 | -176.84 | -97.12 | -112.67 | -86.32 | -72.11 | -52.23 | -80.45 | -93.12 | -98.99 | -69.90 | -64.41 | -30.68 | -1.37 | 16.52 | 16.52 | 11.02 | 5.07 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
0.8 | 1.1 | 1.3 | 0.8 | 1.2 | 1.8 | 1.6 | 2.1 | 2.4 | 2.9 | 3.2 | 3.2 | 3.2 | 3.2 | 2.8 | 2.8 | 2.8 | 2.8 | 2.4 | 2.4 | 2.4 | 2.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency